GordonMD Global Investments reports $16 million Pyxis Oncology common share purchase
Bitget2026/10/02 12:36- GordonMD Global Investments, a 10% owner of Pyxis Oncology, disclosed a purchase of 5,517,000 common shares.
- Beneficial ownership rose to 15,541,909 shares, held indirectly through GordonMD Long Biased Master Fund.
- The filing also reports the purchase of 7,546,766 common stock purchase warrants with a $3.50 exercise price.
- Warrants are not exercisable until stockholder approval increases authorized common shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pimco warns: 10-year US Treasury yield may hit 6%, for the first time since 2000
PIMCO's Chief Investment Officer stated that due to high oil prices intensifying inflation concerns and market unease over the growing U.S. public debt, the benchmark 10-year U.S. Treasury yield could rise to 6% for the first time since 2000.
Altcoin Rises 138% in One Month and Enters Top 20, What’s Behind the Rally? Here Are the Details
OpenAI's annualized revenue aims for $70 billions, with enterprise business as a driving force
According to sources familiar with the matter, OpenAI is expected to reach or exceed an annualized revenue of 7 billion dollars by the end of this year, mainly driven by the growth of its enterprise business.
Crypto prices
More
